Call for Abstract
13th Asia-Pacific Oncologists Annual Meeting, will be organized around the theme “Form a cancer free globe”
Asia Pacific Oncologists 2016 is comprised of 14 tracks and 56 sessions designed to offer comprehensive sessions that address current issues in Asia Pacific Oncologists 2016.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
A Cancer Biology study explains on the microenvironment, metastasis, angiogenesis, apoptosis, transcription, invasion, tumor suppressor genes, oncogenes, cancer stem cells, resistance to therapy and modelling of tumor.
Genome in a cancer helps torecognize a subtype of cancer within that type. Understanding the cancer genome may also help a doctor select the best treatment for each patient.
Genetic testing now a days madepossible, in some cases to find the individuals who are increasing risk for developing cancer but deciding to be tested in a complex decision.
- Track 1-1Cancer biology
- Track 1-2Cancer genomics
- Track 1-3 Drivers of cancer
- Track 1-4Risk factors
Neuro-oncology evaluates and treats people with primary and secondary tumors of the brain, spinal cord, and the membranes surrounding the brain and spinal cord (meninges).
The maximum kind of brain tumors are gliomas, meningiomas, pituitary adenomas, vestibular schwannomas, and primitive medulloblastoma.The word glioma includes glioblastomas, astrocytomas, oligodendrogliomas, and ependymomas.
Paediatric molecular neuro-oncology is a fast developing arena. A multitude of molecular paediatric brain tumors.
- Track 2-1Pathology and molecular genetics of brain tumor its Staging
- Track 2-2Advanced Imaging of adult brain tumors
- Track 2-3Malignant glimos and olingodendrogliomas in adults
- Track 2-4Pediatric neuro oncology
Oral cancer looks like as a growth or sore in the mouth that does not go away. Oral cancer, which contains cancers of the lips, tongue, cheeks, base of the mouth, hard and soft palate, sinuses, and throat, can be life threatening if not analysed and treated early.
Infection with carcinogenic types of human papillomavirus (HPV), especially HPV-16, is a threat factor for some types of head and neck cancers.
- Track 3-1Head and neck cancer
- Track 3-2Leukoplakia, erythroplakia
- Track 3-3Velscope, vizilite plus, identafi 3000
- Track 3-4Hematopoietic stem cell transplantation and prevention
The most dangerous form of skin cancer is these cancerous growths develop once unrepaired DNA damage to skin cells most frequently caused by ultraviolet radiation from sunshine or tanning beds triggers mutations genetic defects that lead the skin cells to multiply rapidly and form malignant tumors The majority of melanomas are black or brown, but they can also be skin-colour, pink, red, purple, blue or white.
Mohs surgery has been recognized as the solitary most real technique for eradicating Basal Cell Carcinomas and Squamous Cell Carcinomas the two most common skin cancers.
- Track 4-1Melanoma
- Track 4-2Carcinoma
- Track 4-3Symptoms and diagnosis of skin cancer
- Track 4-4Mohs surgery
Most blood cancers, the normal blood cell development process are interrupted by uninhibited growth of an abnormal type of blood cell. Mainly, there are three elementary forms of blood cancer are Leukaemia, Lymphoma, Myeloma.
Bone cancer is a rare cancer that begins in a bone. The cancer that can begin in any bone in the body, but it most usually affects the long bones that make up the arms and legs. Bone cancer is a cancer of the cells that make up the bones of the body. When cancer is found in bones, it has regularly started in another organ or another place in the body and has spread to the bones.
- Track 5-1Lymphoma, leukemia and myeloma
- Track 5-2Ewing’s sarcoma, van nes rotation
- Track 5-3Secondary and metastatic bone cancer
- Track 5-4French-American-British(FAB) staging
- Track 5-5Epigentic alterations as basis for treatment of leukemia
Lung cancer stands first cause of cancer deaths in both men and women around the globe and worldwide Cigarette smoking is the chief risk factor for development of lung cancer.
Mesothelioma is a rare category of cancer that grows in the pleura. It is caused by exposure to asbestos.
Small lung cancer it has named because the cancerous cells are small in size. Non-small cell lung cancers are three kinds’ Squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.
- Track 6-1Small cell lung cancer
- Track 6-2Non Small cell lung cancer
- Track 6-3Symptoms and diagnosis of lung cancer
- Track 6-4 Stages of lung cancer
Wilms tumors are the primary cancers in children that start in the kidneys. Most Wilms tumors are unilateral, which means they affect only one kidney. Most often there is only one tumor, but 5 – 10 % of children with Wilms tumors have more than one tumor in the same kidney. About 5% of children with Wilms tumors have bilateral disease, tumors in both kidneys. Clear cell sarcoma of the kidney they spread to other parts of the body which is hard to cure.
TNM is based on 3 components: Tumor indicates size of a particular tumor. Lymph node indicates whether the cancer has spread to nearby lymph nodes and metastasis whether the cancer has spread to distinct organs.
- Track 7-1Incidence and mortality screening
- Track 7-2 Symptoms and TNM system
- Track 7-3Wilms tumor and its effects
- Track 7-4Radical nephrectomy and I.V pyelography
Breast cancer is a malignant tumor that starts in the cells of the breast. Cells in the breast sometimes change, behave normally. These changes may lead to benign breast conditions such as atypical hyperplasia and cysts. They can also lead to benign tumours such as intraductal papillomas. Benign conditions and tumors are not cancerous. But in some cases, changes to breast cells can cause breast cancer.
Less common types of breast cancer can also develop. These include inflammatory breast cancer, Paget disease of the nipple and triple negative and basal-like breast cancers. Rare types of breast cancer include non-Hodgkin lymphoma and sarcoma.
- Track 8-1Ductal carcinoma In situ and invasive ductal carcinoma
- Track 8-2Triple negative and inflammatory
- Track 8-3Grades and stages of breast cancer
- Track 8-4Mammography and prognosis of breast cancer
Pancreatic cancer is a disease in which malignant cells form in the tissues of the pancreas. It regulates blood sugar levels. Exocrine cells produce the digestive juices; while endocrine pancreas cells produce the hormones majorly cancers start in the exocrine cells.
Mostly, colorectal cancer starts in glandular cells, which make mucus and digestive fluids. These cells line the inside of the colon and rectum. This type of cancer is called adenocarcinoma of the colon and rectum. Changes in the cells of the colon and rectum can also cause precancerous conditions.
- Track 9-1Exocrine and endocrine cancers
- Track 9-2 Pancreatic neuroendocrine tumor (PANnets)
- Track 9-3Stages and symptoms of colorectal cancer
- Track 9-4Surgical methods of colorectal cancer
Reproductive malignancies start in the organs related to reproduction (sex). These organs are located in the pelvis, which is in between the hip bones.
Epithelial cell tumors arise from the surface of the ovaries. Tumors start in the cells that produces the eggs are called germ cell tumors. They can either be benign or cancerous. Most are benign. Stromal tumors originate in the cells that produce female hormones.
Prostate cancer is usually a very slow growing cancer, with no symptoms until it is in an progressive stage. Most men with prostate cancer die of other causes, and many never know that they have the disease. But once prostate cancer begins to grow quickly or spreads outside the prostate, it is dangerous.
- Track 10-1Cervical cancer
- Track 10-2Ovarian cancer
- Track 10-3Choriocarcinoma and childhood cancer
- Track 10-4Prostate and testicular cancer
Hormone therapy changes the amount of hormones that circulate in the blood and regulate the activity of certain cells. Targeted therapy treats the specified target genes, proteins that contribute to cancer growth. Immunotherapy is designed to boost the body’s natural defence mechanism for fighting against cancer.
- Track 11-1Radiotherapy
- Track 11-2Chemotherapy
- Track 11-3Immunotherapy
- Track 11-4Genetherapy
- Track 11-5Photodynamictherapy
- Track 11-6Ayurvedic medication
A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule
Cancer nanotechnology is being enthusiastically evaluated and implemented in cancer treatment indicating a major advance in detection, diagnosis, and treatment of the disease.
Globally it is expected that there are 7.6 million new cancer cases per annum, out of which 52% happen in developing countries. The National Cancer Registry stated that 21,773 cancer cases were diagnosed in Peninsular Malaysia in 2006.
- Track 12-1Biomarkers, vaccines and pathology
- Track 12-2Pharmacodynamics and pharmacokinetics
- Track 12-3Cancer polymeric nanotechnology and drug design
- Track 12-4Adverse effects of chemotherapy
- Track 12-5Prognosis of cancer
- Track 12-6 Environmental carcinogenesis
- Track 12-7Oncology case reports
An Oncology Nurse provides care for cancer patients and those at risk for getting the disease. They monitor physical conditions, prescribe medication, and administer chemotherapy and other treatments. Oncology is one of the most challenging and rewarding fields in nursing and no two days on the job are ever the same.
International Conference on Oncology Nursing and Cancer Care September 19-21, 2016 Las Vegas, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; International Conference on Leukaemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; International Conference on Thyroid Cancer and Treatment Aug 1-3, 2016 Toronto, Canada; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; American Head and Neck Society (AHNS) Annual Meeting April 26-30, San Diego, USA; Enhancer Malfunction in Cancer (Q6) February 21-24, 2016 New Mexico, USA; 2nd EORTC Cancer Survivorship Summit 31 March -1 April 2016, Brussels, Belgium; NCCN 21st Annual Conference: Advancing the Standard of Cancer Care, March 31 - April 1, 2016 Hollywood, USA
- Track 13-1Cancer and Lifestyle Connection
- Track 13-2Preventive oncology
Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy ; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany ; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference on Neuro-Oncology July 21-23, 2016 Brisbane, Australia; 17th International Symposium on Pediatric Neuro-Oncology (ISPNO 2016) June 12 - 16, 2016 Liverpool, USA;140th Annual Meeting of the American Neurological Association 11 -15 September, Sheraton Park, Sydney;11th European Congress of Neuropathology (ECNP) July 06-09, Bordeaux, France; 10th FENS Forum of Neuroscience July 02- 06 Brussels, Belgium; 17th Biennial Canadian Neuro-Oncology June 9-11 Toranto, Canada.